To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ACBD6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
206 supporting clones for gene ACBD6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB092309 testis .a 1 to 546 2 to 548   tiling clone, capped   547/547
(100 %)
2 diff
(99.7 %id)
BI461049 testis .a 10 to 679 1 to 670       670/670
(100 %)
7 diff
(99.0 %id)
BM903957 eye, retinoblastoma .a 25 to 594 1 to 574       574/1325
(43 %)
7 diff
(99.5 %id)
CB053946 brain, glioblastoma (pooled) .a 27 to 667 1 to 641       641/641
(100 %)
5 diff
(99.3 %id)
TI_57243157   .a 34 to 721 28 to 716       689/716
(96 %)
6 diff
(99.2 %id)
BI918243 brain .a 39 to 721 1 to 684       684/684
(100 %)
2 diff
(99.8 %id)
CR602338 fetal brain .a 80 to 1641 1 to 1562 exact     1562/1562
(100 %)
0 diff
(100 %id)
AL537685 brain, fetal brain .a 80 to 953 1 to 872   fully sequenced,   872/872
(100 %)
6 diff
(99.4 %id)
NM_032360.3   .a 80 to 1696 1 to 1617 exact RefSeq,   1617/1617
(100 %)
1 diff
(100.0 %id)
CR626583 B cells (Ramos cell line) Cot 25-normalized .a 86 to 1668 1 to 1583 exact tiling clone,   1583/1583
(100 %)
0 diff
(100 %id)
AL561590 B cells from Burkitt lymphoma .a 86 to 970 1 to 886   fully sequenced,   886/886
(100 %)
4 diff
(99.6 %id)
BQ717797 dorsal root ganglia .a 92 to 801 1 to 721       721/1033
(69 %)
14 diff
(98.7 %id)
DA136477 alzheimer cortex .a 103 to 647 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
TI_57240704   .a 104 to 817 23 to 744       722/813
(88 %)
6 diff
(99.3 %id)
AK314112 alzheimer cortex .a 105 to 1549 1 to 1445 I218V     1445/1445
(100 %)
3 diff
(99.8 %id)
DA136125 alzheimer cortex .a 106 to 744 2 to 640   capped   639/639
(100 %)
2 diff
(99.7 %id)
DA224055 brain .a 106 to 600 2 to 496   capped   495/495
(100 %)
4 diff
(99.2 %id)
DA617487   .a 106 to 684 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BI914704 brain .a 112 to 817 1 to 714       714/783
(91 %)
16 diff
(98.0 %id)
CB150940 cervix, Uterine .a 115 to 654 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
AL561369 B cells from Burkitt lymphoma .a 116 to 930 1 to 814       814/814
(100 %)
16 diff
(98.1 %id)
BG720787 testis .a 123 to 718 1 to 596       596/596
(100 %)
5 diff
(99.2 %id)
BM848643 myeloma .a 127 to 523 1 to 400       400/400
(100 %)
4 diff
(99.0 %id)
BM848548 myeloma .a 128 to 483 1 to 356       356/356
(100 %)
1 diff
(99.8 %id)
DA140658 alzheimer cortex .a 129 to 631 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
TI_57199303   .a 131 to 704 62 to 635       574/635
(90 %)
6 diff
(99.1 %id)
CR596110 Neuroblastoma Cot 10-normalized .a 138 to 1662 1 to 1525 exact     1525/1525
(100 %)
0 diff
(100 %id)
CR597133 Neuroblastoma Cot 50-normalized .a 138 to 1651 1 to 1514 exact     1514/1514
(100 %)
0 diff
(100 %id)
AL521865 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 138 to 969 1 to 831   fully sequenced,   831/831
(100 %)
5 diff
(99.4 %id)
AL530548 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 138 to 970 1 to 831   fully sequenced,   831/831
(100 %)
8 diff
(99.1 %id)
BI821612 pooled brain, lung, testis .a 138 to 704 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BM452460 eye, retinoblastoma .a 138 to 890 1 to 759       759/1088
(69 %)
16 diff
(98.6 %id)
CR616957 Placenta Cot 25-normalized .a 139 to 1648 1 to 1510 exact     1510/1510
(100 %)
0 diff
(100 %id)
AL550949 placenta, Placenta Cot 25-normalized .a 139 to 969 1 to 827   fully sequenced,   827/827
(100 %)
7 diff
(99.2 %id)
CR981982 T-Lymphocytes .a 139 to 789 19 to 669       651/670
(97 %)
1 diff
(99.9 %id)
AL542297 placenta .a 140 to 1087 1 to 947       947/947
(100 %)
8 diff
(99.2 %id)
BE314642 brain, neuroblastoma .a 143 to 929 4 to 794       791/1171
(67 %)
29 diff
(97.6 %id)
BX397894 Placenta Cot 25-normalized .a 144 to 840 9 to 716   fully sequenced,   708/716
(98 %)
68 diff
(90.6 %id)
BG743919 blood, natural killer cells, cell line .a 148 to 877 1 to 725   fully sequenced,   725/725
(100 %)
13 diff
(98.3 %id)
BE732041 choriocarcinoma, placenta .a 150 to 968 1 to 807       807/812
(99 %)
21 diff
(97.5 %id)
BI197361 brain, neuroblastoma .a 150 to 950 1 to 804       804/805
(99 %)
33 diff
(96.0 %id)
BM918067 blood, natural killer cells, cell line .a 150 to 843 1 to 695       695/1144
(60 %)
6 diff
(99.5 %id)
BF316469 brain, neuroblastoma .a 151 to 840 1 to 684       684/686
(99 %)
11 diff
(98.4 %id)
CR596874 T cells (Jurkat cell line) Cot10-normalized .a 152 to 1615 1 to 1464 exact     1464/1464
(100 %)
0 diff
(100 %id)
CR617242 Neuroblastoma Cot 25-normalized .a 152 to 1626 1 to 1475 exact     1475/1475
(100 %)
0 diff
(100 %id)
AL528294 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 152 to 969 1 to 818   fully sequenced,   818/818
(100 %)
6 diff
(99.3 %id)
AL558851 T cells from T cell leukemia .a 152 to 871 1 to 723   fully sequenced,   723/723
(100 %)
7 diff
(99.1 %id)
BU170874 eye, retinoblastoma .a 152 to 1021 1 to 876       876/877
(99 %)
8 diff
(99.1 %id)
CX784419 human embryonic stem cells .a 152 to 964 1 to 813       813/813
(100 %)
3 diff
(99.7 %id)
BU187492 eye, retinoblastoma .a 153 to 794 1 to 647       647/931
(69 %)
29 diff
(96.9 %id)
BQ956489 large cell carcinoma, lung .a 154 to 888 1 to 743       743/1019
(72 %)
27 diff
(97.4 %id)
BF315571 brain, neuroblastoma .a 156 to 898 1 to 730       730/835
(87 %)
24 diff
(97.2 %id)
BU149107 melanotic melanoma, cell line, skin .a 354 to 780 1 to 427       427/1049
(40 %)
8 diff
(99.3 %id)
DB490679 hypothalamus .a 360 to 758 1 to 399       399/400
(99 %)
11 diff
(97.3 %id)
DB493440 hypothalamus .a 360 to 858 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BI753456 brain .a 366 to 1084 1 to 723       723/800
(90 %)
8 diff
(99.0 %id)
BI753460 brain .a 366 to 1084 1 to 740       740/753
(98 %)
28 diff
(96.3 %id)
TI_57218089   .a 366 to 1084 31 to 753       723/830
(87 %)
11 diff
(98.7 %id)
TI_57218093   .a 366 to 1084 27 to 766       740/779
(94 %)
25 diff
(96.8 %id)
CV345228 marrow .a 367 to 669 312 to 10     Submitted on the opposite strand 303/324
(93 %)
0 diff
(100 %id)
BU849947 ovary, teratocarcinoma, cell line .a 368 to 1087 1 to 720       720/864
(83 %)
2 diff
(99.8 %id)
BU856141 ovary, teratocarcinoma, cell line .a 368 to 1087 1 to 720       720/850
(84 %)
3 diff
(99.7 %id)
BU859461 ovary, teratocarcinoma, cell line .a 368 to 1087 1 to 722       722/928
(77 %)
6 diff
(99.4 %id)
BE622237 melanotic melanoma, skin .a 375 to 1084 1 to 698       698/773
(90 %)
20 diff
(97.5 %id)
CN261615 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 382 to 668 1 to 288       288/288
(100 %)
8 diff
(97.3 %id)
BM042436 melanotic melanoma, cell line, skin .a 390 to 1084 1 to 701       703/802
(87 %)
13 diff
(98.4 %id)
BM927379 lymph, lymphoma, cell line .a 391 to 1321 1 to 943       941/1098
(85 %)
18 diff
(98.4 %id)
DA821571 pericardium .a 391 to 952 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BU151078 brain, neuroblastoma, cell line .a 394 to 1171 1 to 782       782/903
(86 %)
8 diff
(99.2 %id)
TI_57166882   .a 398 to 1087 37 to 742       706/754
(93 %)
18 diff
(97.7 %id)
BI833791 pooled pancreas and spleen .a 399 to 1087 1 to 705       705/717
(98 %)
26 diff
(96.4 %id)
BG168588 hypernephroma, cell line, Kidney .a 400 to 1085 1 to 682       680/926
(73 %)
31 diff
(96.7 %id)
T09234   .a 405 to 718 1 to 314       314/314
(100 %)
4 diff
(98.8 %id)
BX489792   .a 406 to 872 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
CD518522 White Matter .a 408 to 1171 1 to 767       767/946
(81 %)
8 diff
(99.2 %id)
DB004428 breast, tumor tissue .a 408 to 961 2 to 559   capped   558/558
(100 %)
5 diff
(99.2 %id)
BU189019 melanotic melanoma, skin .a 409 to 1087 1 to 679       679/879
(77 %)
2 diff
(99.8 %id)
AA085011   .a 413 to 802 1 to 398       398/417
(95 %)
24 diff
(94.3 %id)
BM808015 ovary (pool of 3) .a 414 to 1087 13 to 687       675/1139
(59 %)
11 diff
(99.1 %id)
CB150327 cervix, Uterine .a 415 to 986 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BX643053   .a 418 to 891 7 to 480       474/480
(98 %)
5 diff
(99.0 %id)
BI260615 cervical carcinoma cell line, cervix .a 418 to 1087 1 to 687       687/843
(81 %)
26 diff
(97.0 %id)
BM908572 astrocytoma grade IV, cell line, brain .a 419 to 1087 1 to 669       669/1043
(64 %)
2 diff
(99.9 %id)
DR003079 fetal brain .a 420 to 1157 1 to 739       739/739
(100 %)
5 diff
(99.4 %id)
DN602237 human embryonic stem cells .a 422 to 1265 1 to 844       844/844
(100 %)
0 diff
(100 %id)
BQ923198 eye, normal pigmented retinal epithelium .a 425 to 1274 1 to 853       853/932
(91 %)
11 diff
(98.9 %id)
BM477206 lymph, lymphoma, cell line .a 427 to 1364 1 to 939       939/1086
(86 %)
10 diff
(99.1 %id)
C17664 placenta .a 429 to 858 1 to 425       425/425
(100 %)
11 diff
(97.5 %id)
DR761280 embryonic stem .a 429 to 1097 1 to 669       669/669
(100 %)
0 diff
(100 %id)
CN261620 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 443 to 915 1 to 473       473/473
(100 %)
2 diff
(99.6 %id)
BF794264 lymph, lymphoma, cell line .a 456 to 1171 1 to 715       715/1105
(64 %)
7 diff
(99.4 %id)
CN261617 embryonic stem cells, DMSO-treated H9 cellline .a 459 to 795 9 to 345       337/345
(97 %)
6 diff
(98.3 %id)
CB144881 Liver .a 464 to 882 1 to 419       419/419
(100 %)
0 diff
(100 %id)
BE793365 lung, small cell carcinoma .a 475 to 1087 1 to 612       612/646
(94 %)
3 diff
(99.6 %id)
BQ186879 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 487 to 1087 10 to 610       601/636
(94 %)
9 diff
(98.6 %id)
TI_151732771   .a 487 to 1087 682 to 82       601/1059
(56 %)
3 diff
(99.8 %id)
BI859474 breast, mammary adenocarcinoma, cell line .a 529 to 1218 1 to 689       689/689
(100 %)
9 diff
(98.7 %id)
TI_57188197   .a 529 to 1218 52 to 740       689/689
(100 %)
9 diff
(98.7 %id)
BG394640 eye, retinoblastoma .a 534 to 1087 1 to 555       555/638
(86 %)
9 diff
(98.6 %id)
BE388229 endometrium, adenocarcinoma cell line, uterus .a 552 to 1171 1 to 621       621/637
(97 %)
5 diff
(99.3 %id)
AW068556 Bone, Hip .a 558 to 1124 55 to 625       571/625
(91 %)
6 diff
(99.1 %id)
BG528299 lung, mucoepidermoid carcinoma .a 565 to 1207 1 to 641       641/641
(100 %)
8 diff
(98.8 %id)
BP227980   .a 578 to 1084 1 to 507       507/581
(87 %)
1 diff
(99.9 %id)
BM792799 Ascites, stomach .a 592 to 714 1 to 123       123/123
(100 %)
5 diff
(96.0 %id)
AW631365 2 pooled high-grade transitional celltumors, genitourinary tract .a 596 to 1066 3 to 473       471/473
(99 %)
7 diff
(98.6 %id)
CN261618 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 598 to 1083 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BM467012 duodenal adenocarcinoma, cell line, small intestine .a 603 to 1364 1 to 764       764/1179
(64 %)
5 diff
(99.6 %id)
AL035818 brain .a 607 to 1080 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
AL079381 brain .a 607 to 1198 1 to 591   fully sequenced,   591/591
(100 %)
3 diff
(99.5 %id)
CN261619 embryonic stem cells, DMSO-treated H9 cellline .a 614 to 1221 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
CF126946 Chondrosarcoma Lung Metastasis cell lines, lung .a 615 to 1354 1 to 740       740/740
(100 %)
2 diff
(99.8 %id)
TI_154190027   .a 618 to 1364 56 to 802       747/1067
(70 %)
8 diff
(99.3 %id)
AW246304 lung, small cell carcinoma .a 621 to 1087 12 to 478       467/509
(91 %)
8 diff
(98.5 %id)
BC006505 Lung, small cell carcinoma .a 623 to 1681 1 to 1059 exact available from MGC, AAA   1059/1059
(100 %)
0 diff
(100 %id)
BE206794 lung, small cell carcinoma .a 624 to 1130 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
CN261616 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 637 to 1270 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
BF981974 duodenal adenocarcinoma, cell line, small intestine .a 661 to 1171 1 to 513       513/1124
(45 %)
8 diff
(99.3 %id)
BG007536 placenta_normal .a 665 to 816 162 to 14       149/165
(90 %)
0 diff
(100 %id)
AY606133   .a 667 to 1674 1 to 1050 Q109P A110S M111N Q112A E113G ... AAA   1050/1050
(100 %)
32 diff
(97.0 %id)
BG164855 hypernephroma, cell line, Kidney .a 667 to 1364 1 to 709       705/799
(88 %)
15 diff
(98.2 %id)
BQ881600 brain, neuroblastoma, cell line .a 681 to 1274 1 to 596       596/1012
(58 %)
15 diff
(98.6 %id)
BE260637 brain, neuroblastoma .a 703 to 1364 1 to 661       661/975
(67 %)
11 diff
(98.9 %id)
AA307794 aorta .a 709 to 1038 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
CN261621 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 713 to 1324 1 to 612       612/612
(100 %)
0 diff
(100 %id)
TI_149301864   .a 766 to 1681 994 to 92   AAA   903/963
(93 %)
18 diff
(98.2 %id)
BE206893 lung, small cell carcinoma .a 780 to 1303 1 to 524   fully sequenced,   524/524
(100 %)
0 diff
(100 %id)
BI094511 cervix .a 780 to 1270 48 to 546       525/942
(55 %)
25 diff
(97.4 %id)
AW374936 colon .a 794 to 1199 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
AI940798 stomach .a 795 to 1168 380 to 4       374/380
(98 %)
6 diff
(98.5 %id)
AI940399 colon .a 803 to 1083 324 to 42       283/324
(87 %)
10 diff
(97.0 %id)
BX351801 Placenta Cot 25-normalized .a 810 to 1678 852 to 1   fully sequenced,   852/852
(100 %)
14 diff
(98.4 %id)
BM888074 eye .a 819 to 1364 1 to 547       547/678
(80 %)
8 diff
(98.9 %id)
AW411000 muscle, rhabdomyosarcoma .a 822 to 1265 21 to 464       444/464
(95 %)
6 diff
(98.8 %id)
AL580577 T cells from T cell leukemia .a 841 to 1615 764 to 1   fully sequenced,   764/764
(100 %)
0 diff
(100 %id)
BE250238 muscle, rhabdomyosarcoma .a 842 to 1115 1 to 274   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
BG744602 blood, natural killer cells, cell line .a 847 to 1606 783 to 23   fully sequenced,   761/783
(97 %)
1 diff
(99.9 %id)
AL566938 brain, fetal brain .a 892 to 1641 749 to 1   fully sequenced,   749/749
(100 %)
1 diff
(99.9 %id)
FN151511 breast carcinoma .a 916 to 1030 116 to 1     Submitted on the opposite strand 116/120
(96 %)
4 diff
(96.7 %id)
DN913042   .a 918 to 1346 559 to 131       429/559
(76 %)
1 diff
(99.9 %id)
DN913041   .a 921 to 1451 34 to 564       532/564
(94 %)
6 diff
(99.0 %id)
BM824775 Ascites, stomach .a 932 to 1422 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BF758970 colon .a 934 to 1087 238 to 85     Submitted on the opposite strand 154/238
(64 %)
0 diff
(100 %id)
AL521864 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 939 to 1654 722 to 9   fully sequenced,   714/722
(98 %)
9 diff
(98.8 %id)
AL563114 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 939 to 1626 689 to 1   fully sequenced,   689/689
(100 %)
5 diff
(99.3 %id)
AL574669 placenta, Placenta Cot 25-normalized .a 939 to 1648 710 to 1   fully sequenced,   710/710
(100 %)
1 diff
(99.9 %id)
AL530547 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 940 to 1651 712 to 1   fully sequenced,   712/712
(100 %)
10 diff
(98.6 %id)
AL582758 B cells from Burkitt lymphoma .a 940 to 1665 728 to 4   fully sequenced,   725/728
(99 %)
1 diff
(99.9 %id)
BM701521 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 941 to 1323 1 to 383       383/383
(100 %)
0 diff
(100 %id)
BQ014159 Chondrosarcoma, Left Pubic Bone .a 1005 to 1681 694 to 19   AAA   676/676
(100 %)
1 diff
(99.9 %id)
BM980152 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1009 to 1681 691 to 19   AAA   673/673
(100 %)
0 diff
(100 %id)
CD364717 Alveolar Macrophage, lung .a 1009 to 1681 691 to 19   AAA   673/673
(100 %)
1 diff
(99.9 %id)
BE175158 head_neck .a 1011 to 1260 6 to 255       250/258
(96 %)
10 diff
(96.2 %id)
AA081196   .a 1019 to 1304 1 to 293   fully sequenced,   293/293
(100 %)
7 diff
(97.7 %id)
EB386384 eye, optic nerve .a 1028 to 1680 1 to 653       653/658
(99 %)
1 diff
(99.9 %id)
BE250478 muscle, rhabdomyosarcoma .a 1054 to 1639 589 to 3   fully sequenced,   587/589
(99 %)
1 diff
(99.9 %id)
BM789330 Ascites, stomach .a 1055 to 1594 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BP332094 renal proximal tubule .a 1058 to 1635 1 to 579       579/584
(99 %)
9 diff
(98.5 %id)
CB053945 brain, glioblastoma (pooled) .a 1061 to 1681 644 to 24   AAA   621/621
(100 %)
0 diff
(100 %id)
TI_149272394   .a 1073 to 1681 702 to 93   AAA   610/1029
(59 %)
8 diff
(99.3 %id)
BM042838 melanotic melanoma, cell line, skin .a 1079 to 1611 573 to 26       548/758
(72 %)
20 diff
(97.4 %id)
AW068557 Bone, Hip .a 1079 to 1672 602 to 8       595/625
(95 %)
2 diff
(99.7 %id)
TI_149302045   .a 1079 to 1681 681 to 83   AAA   599/782
(76 %)
17 diff
(97.9 %id)
TI_227713979   .a 1079 to 1681 697 to 95   AAA   603/952
(63 %)
2 diff
(99.8 %id)
AA380548   .a 1083 to 1371 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AA522707 lung, lung tumor .a 1098 to 1681 605 to 33   AAA   573/642
(89 %)
19 diff
(97.1 %id)
BU675040 lung, Primary Lung Epithelial Cells .a 1099 to 1681 602 to 19   AAA   584/584
(100 %)
3 diff
(99.5 %id)
TI_149308726   .a 1107 to 1681 673 to 100   AAA   574/979
(58 %)
5 diff
(99.5 %id)
BE855801 brain, glioblastoma (pooled) .a 1122 to 1681 560 to 1       560/560
(100 %)
0 diff
(100 %id)
BE858066 brain, glioblastoma (pooled) .a 1130 to 1681 552 to 1       552/552
(100 %)
1 diff
(99.9 %id)
AL079382 brain .a 1137 to 1680 563 to 21   fully sequenced, AAA   543/543
(100 %)
4 diff
(99.3 %id)
T94828 lung .a 1137 to 1394 1 to 259       259/323
(80 %)
2 diff
(99.4 %id)
BU687188 lung .a 1151 to 1681 549 to 19   AAA   531/531
(100 %)
0 diff
(100 %id)
BI494435 cochlea, ear .a 1166 to 1673 11 to 518   fully sequenced, AAA   510/520
(98 %)
6 diff
(98.9 %id)
AA742684 pooled germ cell tumors .a 1177 to 1681 505 to 1       505/505
(100 %)
0 diff
(100 %id)
AA663432   .a 1188 to 1681 530 to 36   AAA   495/495
(100 %)
5 diff
(99.0 %id)
AA634176 lung .a 1214 to 1681 482 to 14   AAA   469/469
(100 %)
1 diff
(99.8 %id)
AA639453 colon, colon tumor RER+ .a 1214 to 1662 447 to 1       447/447
(100 %)
5 diff
(98.9 %id)
BE465104 carcinoid, lung .a 1222 to 1681 477 to 18   AAA   460/460
(100 %)
4 diff
(99.2 %id)
AI826835 normal prostate, Prostate .a 1223 to 1681 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AI949197 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1228 to 1681 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI889127 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1229 to 1682 459 to 6       454/459
(98 %)
0 diff
(100 %id)
AI032432 breast .a 1231 to 1680 454 to 5       450/454
(99 %)
0 diff
(100 %id)
BM988241 mixed .a 1231 to 1681 469 to 19   AAA   451/451
(100 %)
0 diff
(100 %id)
BM980312 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1232 to 1681 468 to 19   AAA   450/450
(100 %)
0 diff
(100 %id)
AW614879 2 pooled high-grade transitional celltumors, genitourinary tract .a 1236 to 1689 455 to 2       454/455
(99 %)
5 diff
(99.0 %id)
AW731933 lung, small cell carcinoma .a 1238 to 1681 458 to 15   AAA   444/444
(100 %)
1 diff
(99.8 %id)
BX101883 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1245 to 1681 451 to 15   AAA   437/437
(100 %)
0 diff
(100 %id)
AI093485 uterus .a 1250 to 1681 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI276009 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1250 to 1681 453 to 22   AAA   432/432
(100 %)
1 diff
(99.8 %id)
AW732044 lung, small cell carcinoma .a 1253 to 1682 437 to 8   fully sequenced,   430/437
(98 %)
0 diff
(100 %id)
DB561043 hypothalamus .a 1272 to 1681 7 to 414     Submitted on the opposite strand 408/414
(98 %)
4 diff
(99.1 %id)
AA081098   .a 1272 to 1676 416 to 8   fully sequenced,   409/416
(98 %)
3 diff
(99.3 %id)
AA576269 breast, breast tumor .a 1286 to 1684 420 to 22   AAA   399/399
(100 %)
5 diff
(98.8 %id)
AA635591 normal prostate, Prostate .a 1295 to 1694 400 to 1       400/400
(100 %)
0 diff
(100 %id)
D45499 lung .a 1301 to 1611 1 to 311     Submitted on the opposite strand 311/311
(100 %)
1 diff
(99.7 %id)
BM987258 mixed .a 1319 to 1681 381 to 19   AAA   363/363
(100 %)
0 diff
(100 %id)
AW205806   .a 1335 to 1681 364 to 18   AAA   347/347
(100 %)
0 diff
(100 %id)
TI_154135434   .a 1357 to 1681 427 to 103   AAA   325/588
(55 %)
3 diff
(99.5 %id)
AA055775 colon, tumor .a 1362 to 1681 334 to 13   AAA   322/328
(98 %)
2 diff
(99.4 %id)
BI494434 cochlea, ear .a 1362 to 1649 287 to 1   fully sequenced,   288/288
(100 %)
3 diff
(99.0 %id)
AA085012   .a 1380 to 1695 317 to 2   tiling clone,   316/441
(71 %)
0 diff
(100 %id)
BG057002 anaplastic oligodendroglioma, brain .a 1380 to 1681 320 to 19   AAA   302/309
(97 %)
10 diff
(96.8 %id)
AA149766 colon, tumor .a 1390 to 1682 295 to 1       295/468
(63 %)
4 diff
(99.2 %id)
AL582691 B cells from Burkitt lymphoma .a 1394 to 1652 259 to 1       259/259
(100 %)
2 diff
(99.3 %id)
AW461297 Kidney .a 1448 to 1673 24 to 248   AAA   225/248
(90 %)
6 diff
(97.6 %id)
AI825141 pooled germ cell tumors .a 1460 to 1689 235 to 6       230/235
(97 %)
0 diff
(100 %id)
DB564520 hypothalamus .a 1490 to 1681 1 to 192     Submitted on the opposite strand 192/192
(100 %)
2 diff
(99.0 %id)
AW958523   .b 1 to 639 2 to 640 exact tiling clone,   640/673
(95 %)
3 diff
(99.6 %id)
DB037089 testis .c 1 to 574 2 to 576   tiling clone, capped   575/575
(100 %)
5 diff
(99.2 %id)
DB337526 testis .c 1257 to 1801 542 to 1   tiling clone,   542/542
(100 %)
1 diff
(99.9 %id)
BE741517 adenocarcinoma cell line, ovary .d 1 to 503 1 to 502 E10K N11T N12T I13L D14T ... tiling clone, AAA   502/502
(100 %)
3 diff
(99.5 %id)
BE292931 adenocarcinoma cell line, colon .e 1 to 671 1 to 669 G71D tiling clone,   669/715
(93 %)
4 diff
(99.5 %id)
TI_44159195   .e 282 to 791 88 to 607   tiling clone,   520/679
(76 %)
22 diff
(96.8 %id)
BI523652 pooled lung and spleen .e 291 to 791 30 to 550       531/622
(85 %)
72 diff
(88.5 %id)
H62751 liver and spleen .e 495 to 964 1 to 476   tiling clone,   476/476
(100 %)
20 diff
(95.8 %id)
BI524807 pooled lung and spleen .e 886 to 1700 834 to 5   tiling clone,   830/834
(99 %)
0 diff
(100 %id)
TI_44159196   .e 886 to 1700 834 to 5       830/834
(99 %)
0 diff
(100 %id)
BU853108 testis .f 1 to 426 8 to 433 exact tiling clone,   426/467
(91 %)
8 diff
(98.3 %id)
AI961058 pooled germ cell tumors .f 52 to 504 458 to 6   tiling clone,   453/458
(98 %)
0 diff
(100 %id)
BU661202 blood .f 304 to 988 692 to 8   tiling clone, Submitted on the opposite strand 685/692
(98 %)
0 diff
(100 %id)
BE774483 uterus .f 424 to 739 1 to 323   tiling clone,   323/323
(100 %)
24 diff
(92.6 %id)
BF895139 marrow .f 533 to 840 323 to 17     Submitted on the opposite strand 307/345
(88 %)
0 diff
(100 %id)
AW885100 ovary .f 818 to 1021 219 to 17   tiling clone,   203/222
(91 %)
0 diff
(100 %id)
BF935681 nervous_tumor .g 1 to 233 9 to 244 exact tiling clone,   236/259
(91 %)
14 diff
(94.6 %id)
BP289884 lung Gene ACBD6, variant not shown         This clone was ignored    
BE011501 breast_normal Gene ACBD6, variant not shown              
DB358123 whole embryo, mainly head Gene ACBD6, variant not shown         Suspected internal deletion, this clone was ignored    
DA571280 whole embryo, mainly head Gene ACBD6, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB322327   Gene ACBD6, variant not shown              
DA673682   Gene ACBD6, variant not shown       capped      
BF796867 lymph, lymphoma, cell line Gene ACBD6, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C